Articles By Kathryn H. Dao, M.D.
Rebuttals
Since the COVID vaccine rollout, more people have been eligible to receive the vaccine. However, not everyone chooses to get one. I have heard many reasons (aka excuses) from my patients who are vaccine hesitant.
Read Article
Best of 2020: My Experience as a COVID19 Vaccine Trial Participant
I have been an investigator for many clinical rheumatology studies over the past two decades but have never been a study subject until now. On October 31, 2020, I enrolled in the phase 3 trial of the Pfizer/BioNTech mRNA vaccine against SARS-CoV2 (protocol C4591001). Here's my experience.
Read Article
Best of 2020: The COVID-19 Global Rheumatology Registry
What started out as online tweets and sharing newsfeed and case reports, has progressed to the formation of the COVID-19 Global Rheumatology Alliance, whose mission is to create an international rheumatology registry of patients affected by the disease in order to better understand the disease and guide clinicians in assessing and treating patients.
Read Article
Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps
Ready for telemedicine/telerheumatology? Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.
Read Article
My Experience as a COVID19 Vaccine Trial Participant
I have been an investigator for many clinical rheumatology studies over the past two decades but have never been a study subject until now. On October 31, 2020, I enrolled in the phase 3 trial of the Pfizer/BioNTech mRNA vaccine against SARS-CoV2 (protocol C4591001). Here's my experience.
Read Article
Flu and Tofacitinib
Dr. Kathryn Dao reviews abstract L04 - Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program - at the 2020 ACR annual meeting.
Read Article
A Convergence of Ideas: COVID19 and ACR
Since the beginning of the pandemic, rheumatologists scrambled to figure out how the SARS-CoV-2 virus will affect their patients with immune mediated inflammatory diseases (IMID). Meeting the needs of patients, managing a practice, and trying to balance a home life have many doctors stressed.
Read Article
ICYMI: Telemedicine Bloopers and Successes
At my COVID home command center, I feel pretty prepared for everything. From here, I can run my practice, manage and home-school 3 children and keep the family afloat. I have 2 computers: one for telemedicine/business meetings and one for e-learning lessons/school updates that teachers and school administrators email me throughout the day for my children. As a no-nonsense, organized mom and doctor, I felt ready to handle any issues that would arise.
Read Article
Change from Within
I attended the #whitecoats4blacklives rally at Dallas City Hall a few weeks ago to support our black colleagues, patients, and friends. It was inspiring, humbling, and emotional. I encouraged other physicians to join me, posting on the Dallas Physician Facebook page that we need to lead by example for our community and our children to fight structural racism. One black physician posed a very important point to my post, “What permanent changes will you make in your personal and professional lives as a result of this? Because not endorsing racism is not the same as not being complicit in it.”
Read Article
Year of the Wolf: Lupus at EULAR2020
For a disease that has been recognized since the days of Hippocrates, we are finally making some progress towards understanding systemic lupus erythematosus (SLE) and how to tame the wolf. Listed below are the top 5 studies and their summaries presented at the recent EULAR e-Congress confer
Read Article